This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Narcolepsy Treatment Market

Market Insights on Narcolepsy Treatment covering sales outlook, demand forecast & up-to-date key trends

Narcolepsy treatment Market by Product (Narcolepsy Treatment Drugs and Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-commerce, Drug Stores and Others) & Region for 2022-2028

Narcolepsy treatment Market Outlook - 2022-2028

[155 Pages Report] The global Narcolepsy Treatment Market is estimated at USD 4.77 billion in 2022 and is projected to reach USD 6.67 billion by 2028, growing at a CAGR of 5.7% during the forecast period (2022-2028).  

Data Points

Market Insights

Market Value 2021

US$ 4.50 Bn

Market Value 2022

US$ 4.77 Bn

Market Value 2028

US$ 6.67 Bn

CAGR 2022-2028

5.7%

Market Share of Top 5 Countries

54.4%

Key Industry Players

ResMed Inc., Koninklijke Philips N.V., Merck & Co. Inc., Drive DeVilbiss Healthcare LLC, GlaxoSmithKline Plc., Fisher & Paykel Healthcare Limited, Pfizer Inc.

Over the past few decades, the neurobiology of sleep has witnessed a substantial progress owing to the increasing development of animal models for understanding neurological functions of the brain and the complexities that may exist. This also includes the brain’s function in terms of sleep.

With the recent advent of the COVID-19 pandemic, there is a significant burden of respiratory distress caused by novel coronavirus, leading to respiratory failure and deaths associated with it, all across the globe. The burden has also led to a rise in sleep related disorders such as narcolepsy and cataplexy.

To promote awareness regarding sleep disorders and the availability of treatments associated with narcolepsy, various local, national and international institutes, councils and organizations have taken initiative approaches to raise informative facts on available options of narcolepsy treatment.

The rising awareness among patients due to the initiatives undertaken by such organizations are expected to prompt the understanding among people with regard to medications and treatment options available for narcolepsy.

Thus, the narcolepsy treatment market growth is provoked by the rising prevalence of sleep-related neurological disorders, increasing awareness regarding neurological disorders and the emergence of local pharmaceutical players.

The leading manufacturers operating in the global narcolepsy treatment market are focusing on launching new products and promoting their brands in order to gain maximum market share.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

5.74%

H1, 2022 Projected

5.75%

H1, 2022 Outlook

5.65%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 9 ↓

FMI presents a comparative analysis about the market growth rates and development prospects in the global narcolepsy treatment market. The market is subject to influence by rise in patient base, high product adoption rate in accordance with impact of macro and industry factors.

Key developments in this market include development of novel therapeutics, favourable government policies for start-ups and attractive reimbursement opportunities for patients.

According to FMI, the narcolepsy treatment market is expected to decrease by 09 Basis Point Share (BPS) in H1-2022 when compared with H1-2021. When comparing H1-2022 outlook and H1-2022 Projected growth, the difference of 10 BPS was observed.

Key factors involved in the decrease of BPS is attributed to the disruption caused by the advent of the COVID-19 pandemic, leading to delays by manufacturers or their partners in the initiation or enrolment of patients in clinical trials, difficulties launching or commercialising products, patient discontinuations in clinical trials, and other related activities, which could cause ongoing clinical trials to be delayed, reduce royalty revenues, increase development costs, and have a material adverse effect on manufacturers' financial condition, business, and operational results.

There are some plus points that stay ahead for the industry which include development of primary healthcare facilities and need for development of personalised medicine for orphan drugs.

Sales Analysis of Narcolepsy treatment from 2013 to 2021 Vs Market Outlook for 2022 to 2028

The market value for narcolepsy treatment holds nearly 5.6% of the overall US$ 80.0 Bn sleep aids market in 2021.

The prevalence of disorders such as cataplexy, sleep paralysis and excessive daytime sleepiness (EDS) is increasing over the globe. There is an active association by many organizations worldwide for an intent to increase awareness regarding such neurological disorders which associate with sleep disturbances and respiratory distress.

Some active organizations include the Narcolepsy Network Inc., Wake up Narcolepsy, the American Sleep Association and the European Narcolepsy Network.

Furthermore, the use of modafinil for treatment of patients with narcolepsy has shown lesser side-effects, and has enhanced the growth of the narcolepsy treatment market. The growth of the narcolepsy treatment market is associated with the higher efficacy of modafinil than traditional stimulants for prevention of sleep disorders.

There have been major advances in the field of neurobiology on the basis of narcolepsy, but the management of narcolepsy disorder remains symptomatic in the current scenario. The management of excessive daytime sleepiness is done with psychostimulants such as armodafinil and amphetamines as a form of third-line therapy.

Narcolepsy Treatment Market Download Report Brochure

Narcolepsy treatment market has thus been an active area for drug development and advancement of wake-promoting agents over the past few years.

The global narcolepsy treatment market expanded at 5.1% CAGR over the past 8 years from 2013 to 2021. The market is expected to expand at a considerable growth rate over the next six years at a CAGR of close to 5.7%.

What are the Key Opportunities for Narcolepsy treatment Manufacturers?

High disease burden of sleep related disorders over the globe, such as obstructive sleep apnea is continuously providing an opportunity for key players in the sleep aids market to explore novel product concentrations for the management of sleep associated disorders. Sleep apnea is transforming into an important cause of medical morbidity and mortality.

Increasing prevalence of sleep apnea and other sleep related disorders increases the demand for drugs and devices used for treating them. This is set to increase the global narcolepsy treatment market growth over the forecast period.

Moreover, there is a limited presence of manufacturers within the narcolepsy market. In countries, such as China and India, the primary healthcare facilities have a limited capacity due to a large population base. However, prevalence of sleep disorders, such as insomnia, narcolepsy and sleep apnea, is high and majority of the patients remain untreated due to limited resources.

Advanced healthcare technologies, such as sleep disorder diagnostic and therapeutic devices, will widen the scope for improvements in healthcare facilities in developing nations.

Additionally, narcolepsy treatment market also presents a lucrative stance in the development of personalized medicine for orphan diseases owing to the existing clinical, biological and genetic profiles of the disorder. This factor will aid in research and development processes for new drug development, and thus propel the growth of narcolepsy treatment market during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Demand for Narcolepsy treatment?

Lack of early diagnosis of sleep related problems can result into development of chronic conditions such as the risk of heart failure, high blood pressure, stroke, diabetes and obesity. Sleep disorders such as Obstructive Sleep Apnea (OSA) have a high global prevalence, however, there is lack of awareness regarding OSA and the symptoms are deemed inconsequential by many people suffering from it, thus impacting the quality of life of an individual, as well as their productivity.

The availability of drugs for the treatment of narcolepsy and insomnia is apparent in the market for use, however, side effects associated with the uptake of such stimulants has proven to be risk inducing, and is thus responsible for the hampered growth of narcolepsy treatment market.

Furthermore, the addictive nature of sleep inducing drugs prescribed for individuals with sleep disorders has raised concern regarding the administration of these drugs for a longer term. The side effects and the addictive nature of treatment drugs for narcolepsy pose as great threat to the growth of narcolepsy treatment market.

Dearth of skilled medical personnel for operating sleep devices, especially in developing economies has acted as a hindrance in the growth of narcolepsy treatment market across the globe.

The lack of accurate documentation for usage and licensing of sleeping pills, and improper standardization of equipment related with sleep devices such as CPAP and BiPAP are some additional factors responsible for slow growth of sleep aids market and thus narcolepsy treatment market worldwide.

Country-wise Insights

What Makes the U.S. the Largest Market for Narcolepsy treatment?

The U.S. dominates the North American region with a total market share of nearly 91.4% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The growth of this market is driven by advanced healthcare systems in the region and rising efforts by various organizations to spread awareness among the general population on the prevalence of narcolepsy and sleep associated disorders. One such example is the establishment of the American Sleep Association in the country.

Why is Germany Considered a Lucrative Segment for Narcolepsy treatment Market in Europe?

Germany exhibited a market value share growth of nearly 22.4% in the Europe narcolepsy treatment market in 2021 and is expected to hold a market value share of 24.6% by the end of 2028. The growth is associated with the framework associated with new guidelines framed by the combined efforts of European Sleep Research Society (ESRS), European Academy of Neurology (EAN) and European Narcolepsy Network (EU-NN) for treatment of narcolepsy and associated sleep disorders in adults and children in the region.

In addition, favourable reimbursement policies for therapeutic products, strong clinical pipeline, and rising stress levels are the other factors anticipated to promote revenue growth.

What Makes China an Emerging Country for Narcolepsy treatment Market?

China holds 28.2% share in the APAC narcolepsy treatment market in 2021, and is projected to grow at a lucrative rate of CAGR 9.8% during the forecast period. The growth of the narcolepsy treatment market in the country is attributed to the high prevalence of the disorder in the country and relatively less awareness among the general population in terms of the symptoms associated with narcolepsy.

The generative efforts to increase public awareness regarding sleep disorders including narcolepsy have led to the country being a lucrative segment for the growth of narcolepsy treatment market, given that there is an emergence of local pharmaceutical players in China.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Narcolepsy treatment Product is Driving Market Growth?

Devices in narcolepsy treatment project a lucrative growth at a CAGR of 5.9% till the end of the forecast period, with the current market share of around 63.2% in 2021. This dominant market value is associated with the efficacy of devices such as CPAP and BiPAP machines in assistive breathing, thus providing relief from respiratory distress, and resulting in subsequent improvement in sleep and enhanced quality of life.

Which Distribution Channel Shows Preferable Implementation in Narcolepsy treatment market?

E-commerce holds current global narcolepsy treatment market value share of 19.6% in 2021, and is projected to achieve an estimated growth CAGR of 8.0% by the end of the forecast period. This growth is linked with the availability of devices for sleep apnea over electronic media, thus proving to be accessible within areas of low resource availability along with the lack of presence of local distributors.

What is the Impact of COVID-19 on the Narcolepsy treatment Market?

The impact of the COVID-19 pandemic on the narcolepsy treatment market was highly restrictive and steeped negatively on the growth of the narcolepsy treatment market during the year 2020. The occurrence of patients suffering from acute respiratory distress syndrome witnessed an increase during the advent of the COVID-19 pandemic, owing to high prevalence of infection spread throughout the globe. This factor developed into severe shortage in number of available hospital beds and medical equipment.

The initiation of quarantine practices and lockdown impositions in several global regions posed an impact on the light-dark cycle among individuals, thus disrupting the circadian system. The eventual progression of exacerbated symptoms associated with existing narcolepsy surfaced through the disruption in the circadian rhythm.

The global trend also witnessed an increasing emergence in excessive daytime sleepiness, which led to an increase in the use of stimulants. With increased burden of disease, the increasing patient base for sleep related disorders and narcolepsy suffered a restrictive growth in terms of treatment options due to the manufacturing activities being focused on production of drugs and equipment needed for the treatment of COVID-19.

Subsequently, the relevance of impact of sleep associated disorders during the beginning of the COVID-19 pandemic has led to increased research on symptomatic treatment of narcolepsy, followed by the development of stimulants. This is expected to slowly increase the growth of the narcolepsy treatment market over the forecast period.

Competitive Landscape

Key players in the narcolepsy treatment market focus on the acquisition of biopharmaceutical companies and possess a large pipeline for new molecular entities. Key players also collaborate and form alliance for product development and commercialization. Furthermore, major players focus on geographic expansion through inorganic growth strategy.    

  • In January 2020, Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, entered into an agreement with Pfizer Inc. for an exclusive U.S. license to Pfizer’s clinical and nonclinical data, and intellectual property for reboxetine, the active pharmaceutical ingredient in AXS-12 which Axsome is developing for the treatment of narcolepsy.
  • In November 2020, Royal Philips, a global leader in health technology, announced the launch of Philips Ventilator BiPAP A40 EFL. With the introduction of this non-invasive ventilator, Philips extended its homecare solutions with a new ventilation therapy feature for chronic obstructive pulmonary disease (COPD) patients to breathe easier.

Similarly, recent developments related to companies manufacturing narcolepsy treatment market services and technologies have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as Per Narcolepsy Treatment Industry Analysis

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2013-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, APAC, Middle East & Africa (MEA)

Key Countries Covered

US, Canada,  Brazil,  Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, India, ASEAN, Australia, New Zealand, South Africa and GCC Countries

Key Market Segments Covered

Product, Distribution Channel and Region

Key Companies Profiled

  • ResMed Inc.
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Drive DeVilbiss Healthcare LLC
  • GlaxoSmithKline Plc.
  • Fisher & Paykel Healthcare Limited
  • Pfizer Inc.

Pricing

Available upon Request

Key Market Segments Covered in Narcolepsy Treatment Market Research

By Product:

  • Narcolepsy Treatment Drugs
    • Modafinil
    • Sodium Oxybate
    • Armodafinil
    • Others
  • Devices
    • CPAP Devices
    • BiPAP Devices
    • APAP Devices

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • e-commerce
  • Drug Stores
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Frequently Asked Questions

The global narcolepsy treatment market is worth US$ 4.50 Bn in 2021.

The narcolepsy treatment market is expected to reach US$ 6.67 Bn by the end of 2028, with sales revenue expected to register 5.7% CAGR growth.

From 2013-2021, the market for narcolepsy treatment expanded at the rate of 5.1%.

The U.S., Germany, China, U.K. and Brazil are expected to drive demand for narcolepsy treatment market.

North America is one of the key segments for narcolepsy treatment market, with the U.S. expected to account over 89.9% of the North American market during the forecast period.

Demand for narcolepsy treatment in Europe is expected to register growth of 4.6% over the forecast period.

The U.S., China and Germany are key producers of narcolepsy treatment services.

China narcolepsy treatment market appears to uphold a revenue share of 28.2% in the APAC narcolepsy treatment market in 2021. Japan holds a revenue share of 20.7% in the APAC region in 2021, and is expected to grow at a CAGR of nearly 6.9%.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

3. Narcolepsy Treatment Market Opportunity Analysis

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. Market Background

    4.1. Market Dynamics

        4.1.1. Drivers

        4.1.2. Restraints

        4.1.3. Trends

    4.2. Epidemiology Study

    4.3. Pipeline Assessment

5. Global Economic Outlook

    5.1. Gross Domestic Product by Region & Country, 2016 – 2021

    5.2. Global Healthcare Market Indicators

6. North America Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    6.1. Introduction

    6.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021

        6.2.1. U.S.

        6.2.2. Canada

    6.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    6.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021

        6.4.1. Narcolepsy Treatment Drugs

            6.4.1.1. Modafinil

            6.4.1.2. Sodium Oxybate

            6.4.1.3. Armodafinil

            6.4.1.4. Others

        6.4.2. Devices

            6.4.2.1. CPAP Devices

            6.4.2.2. BiPAP Devices

            6.4.2.3. APAP Devices

    6.5. Market Size (US$ Mn) Forecast By Product, 2022-2028

    6.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021

        6.6.1. Hospital Pharmacies

        6.6.2. Retail Pharmacies

        6.6.3. e-commerce

        6.6.4. Drug Stores

        6.6.5. Others

    6.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    6.8. Market Attractiveness Analysis

        6.8.1. By Country

        6.8.2. By Product

        6.8.3. By Distribution Channel

7. Latin America Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021

        7.2.1. Brazil

        7.2.2. Mexico

        7.2.3. Rest of Latin America

    7.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    7.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021

        7.4.1. Narcolepsy Treatment Drugs

            7.4.1.1. Modafinil

            7.4.1.2. Sodium Oxybate

            7.4.1.3. Armodafinil

            7.4.1.4. Others

        7.4.2. Devices

            7.4.2.1. CPAP Devices

            7.4.2.2. BiPAP Devices

            7.4.2.3. APAP Devices

    7.5. Market Size (US$ Mn) Forecast By Product, 2022-2028

    7.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021

        7.6.1. Hospital Pharmacies

        7.6.2. Retail Pharmacies

        7.6.3. e-commerce

        7.6.4. Drug Stores

        7.6.5. Others

    7.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    7.8. Market Attractiveness Analysis

        7.8.1. By Country

        7.8.2. By Product

        7.8.3. By Distribution Channel

8. Europe Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021

        8.2.1. Germany

        8.2.2. U.K

        8.2.3. France

        8.2.4. Italy

        8.2.5. Spain

        8.2.6. Russia

        8.2.7. Poland

        8.2.8. Rest of Europe

    8.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    8.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021

        8.4.1. Narcolepsy Treatment Drugs

            8.4.1.1. Modafinil

            8.4.1.2. Sodium Oxybate

            8.4.1.3. Armodafinil

            8.4.1.4. Others

        8.4.2. Devices

            8.4.2.1. CPAP Devices

            8.4.2.2. BiPAP Devices

            8.4.2.3. APAP Devices

    8.5. Market Size (US$ Mn) Forecast By Product, 2022-2028

    8.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021

        8.6.1. Hospital Pharmacies

        8.6.2. Retail Pharmacies

        8.6.3. e-commerce

        8.6.4. Drug Stores

        8.6.5. Others

    8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    8.8. Market Attractiveness Analysis

        8.8.1. By Country

        8.8.2. By Product

        8.8.3. By Distribution Channel

9. Asia Pacific Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021

        9.2.1. China

        9.2.2. India

        9.2.3. Japan

        9.2.4. Australia and New Zealand

        9.2.5. ASEAN

        9.2.6. Rest of APAC

    9.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    9.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021

        9.4.1. Narcolepsy Treatment Drugs

            9.4.1.1. Modafinil

            9.4.1.2. Sodium Oxybate

            9.4.1.3. Armodafinil

            9.4.1.4. Others

        9.4.2. Devices

            9.4.2.1. CPAP Devices

            9.4.2.2. BiPAP Devices

            9.4.2.3. APAP Devices

    9.5. Market Size (US$ Mn) Forecast By Product, 2022-2028

    9.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021

        9.6.1. Hospital Pharmacies

        9.6.2. Retail Pharmacies

        9.6.3. e-commerce

        9.6.4. Drug Stores

    9.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    9.8. Market Attractiveness Analysis

        9.8.1. By Country

        9.8.2. By Product

        9.8.3. By Distribution Channel

10. Middle East and Africa Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis by Country, 2013-2021

        10.2.1. GCC Countries

        10.2.2. South Africa

        10.2.3. Rest of Middle East and Africa

    10.3. Market Size (US$ Mn) Forecast By Country, 2022-2028

    10.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2013-2021

        10.4.1. Narcolepsy Treatment Drugs

            10.4.1.1. Modafinil

            10.4.1.2. Sodium Oxybate

            10.4.1.3. Armodafinil

            10.4.1.4. Others

        10.4.2. Devices

            10.4.2.1. CPAP Devices

            10.4.2.2. BiPAP Devices

            10.4.2.3. APAP Devices

    10.5. Market Size (US$ Mn) Forecast By Product, 2022-2028

    10.6. Historical Market Size (US$ Mn) Trend Analysis by Distribution Channel, 2013-2021

        10.6.1. Hospital Pharmacies

        10.6.2. Retail Pharmacies

        10.6.3. e-commerce

        10.6.4. Drug Stores

        10.6.5. Others

    10.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    10.8. Market Attractiveness Analysis

        10.8.1. By Country

        10.8.2. By Product

        10.8.3. By Distribution Channel

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Analysis

    13.1. Competition Dashboard

    13.2. Competitors Deep Dive

        13.2.1. Merck & Co. Inc.

        13.2.2. Pfizer Inc.

        13.2.3. ResMed Inc.

        13.2.4. GlaxoSmithKline Plc.

        13.2.5. Fisher & Paykel Healthcare Limited

        13.2.6. Drive DeVilbiss Healthcare LLC

        13.2.7. Koninklijke Philips N.V.

14. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028 by Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis by Region

        14.2.1. North America

        14.2.2. Latin America

        14.2.3. Europe

        14.2.4. Asia Pacific

        14.2.5. Middle East and Africa

    14.3. Market Size (US$ Mn) Forecast By Region

    14.4. Market Attractiveness Analysis by Region

15. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Product

    15.1. Introduction/Key Finding

    15.2. Historical Market Size (US$ Mn) Analysis by Product, 2013-2021

        15.2.1. Narcolepsy Treatment Drugs

            15.2.1.1. Modafinil

            15.2.1.2. Sodium Oxybate

            15.2.1.3. Armodafinil

            15.2.1.4. Others

        15.2.2. Devices

            15.2.2.1. CPAP Devices

            15.2.2.2. BiPAP Devices

            15.2.2.3. APAP Devices

        15.2.3. Market Size (US$ Mn) Forecast By Product, 2022-2028

        15.2.4. Market Attractiveness Analysis by Product

16. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Distribution Channel

    16.1. Introduction/Key Finding

    16.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2013-2021

        16.2.1. Hospital Pharmacies

        16.2.2. Retail Pharmacies

        16.2.3. e-commerce

        16.2.4. Drug Stores

        16.2.5. Others

    16.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    16.4. Market Attractiveness Analysis by Distribution Channel

17. Global Narcolepsy Treatment Market Analysis 2013–2021 and Forecast 2022–2028

    17.1. Market Value Share Analysis by All Segment

    17.2. Y-o-Y Growth Analysis by All Segment

    17.3. Absolute $ Opportunity

18. Assumptions and Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 03: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 04: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product

Table 05: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 06: Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 07: Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product

Table 08: Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 09: Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 10: Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product

Table 11: Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 12: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 13: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product

Table 14: Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 15: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country

Table 16: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product

Table 17: Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User

Table 18: Global Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region

Table 19: Global Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product

Table 20: Global Narcolepsy Treatment Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Narcolepsy Treatment Market Value Share by Region (2022)

Figure 2: Percentage of adults aged 20 and over using prescription sleep aids, by age: United States, 2005–2010

Figure 3: Global Healthcare Expenditure in US$ Tn (2013–2021)

Figure 4: North America Narcolepsy Treatment Market Value Share (2021A), By Country

Figure 5: North America Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel

Figure 6: North America Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 7:  North America Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028

Figure 8:  North America Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028

Figure 9:  U.S. Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 10:  U.S. Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 11:  Canada Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 12:  Canada Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 13:  North America Narcolepsy Treatment Market Attractiveness Analysis, By Country

Figure 14:  North America Narcolepsy Treatment Market Attractiveness Analysis, By Product

Figure 15:  North America Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 16:  Latin America Narcolepsy Treatment Market Value Share (2021A), By Country

Figure 17:  Latin America Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel

Figure 18:  Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 19:  Latin America Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028

Figure 20:  Latin America Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028

Figure 21:  Brazil Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 22:  Brazil Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 23:  Mexico Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 24:  Mexico Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 25:  Rest of Latin America Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 26:  Rest of Latin America Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 27:  Latin America Narcolepsy Treatment Market Attractiveness Analysis, By Country

Figure 28:  Latin America Narcolepsy Treatment Market Attractiveness Analysis, By Product

Figure 29:  Latin America Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 30:  Europe Narcolepsy Treatment Market Value Share (2021A), By Country

Figure 31:  Europe Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel

Figure 32:  Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 33:  Europe Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028

Figure 34:  Europe Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028

Figure 35:  Germany Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 36:  Germany Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 37:  U.K. Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 38:  U.K. Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 39:  France Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 40:  France Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 41:  Italy Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 42:  Italy Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 43:  Spain Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 44:  Spain Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 45:  Russia Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 46:  Russia Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 47:  Poland Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 48:  Poland Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 49:  Rest of Europe Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 50:  Rest of Europe Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 51:  Europe Narcolepsy Treatment Market Attractiveness Analysis, By Country

Figure 52:  Europe Narcolepsy Treatment Market Attractiveness Analysis, By Product

Figure 53:  Europe Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 54:  Asia Pacific Narcolepsy Treatment Market Value Share (2021A), By Country

Figure 55:  Asia Pacific Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel

Figure 56:  Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 57:  Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028

Figure 58:  Asia Pacific Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028

Figure 59:  China Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 60:  China Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 61:  India Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 62:  India Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 63:  Japan Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 64:  Japan Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 65:  Australia & New Zealand Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 66:  Australia & New Zealand Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 67:  ASEAN Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 68:  ASEAN Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 69:  Rest of Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 70:  Rest of Asia Pacific Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 71:  Asia Pacific Narcolepsy Treatment Market Attractiveness Analysis, By Country

Figure 72:  Asia Pacific Narcolepsy Treatment Market Attractiveness Analysis, By Product

Figure 73:  Asia Pacific Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 74:  Middle East & Africa Narcolepsy Treatment Market Value Share (2021A), By Country

Figure 75:  Middle East & Africa Narcolepsy Treatment Market Value Share (2021A), By Product, and Distribution channel

Figure 76:  Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 77:  Middle East & Africa Narcolepsy Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028

Figure 78:  Middle East & Africa Narcolepsy Treatment Market Y-o-Y growth (%) Comparison, By Country, 2022-2028

Figure 79:  GCC Countries Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 80:  GCC Countries Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 81:  South Africa Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 82:  South Africa Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 83:  Rest of MEA Narcolepsy Treatment Market Size (US$ Mn) Analysis, 2013-2021

Figure 84:  Rest of MEA Narcolepsy Treatment Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028

Figure 85:  Middle East & Africa Narcolepsy Treatment Market Attractiveness Analysis, By Country

Figure 86:  Middle East & Africa Narcolepsy Treatment Market Attractiveness Analysis, By Product

Figure 87:  Middle East & Africa Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 88:  Global Narcolepsy Treatment Market Attractiveness Analysis, By Region

Figure 89:  Global Narcolepsy Treatment Market Value Share Analysis, By Region, 2021 & 2028

Figure 90:  Global Narcolepsy Treatment Market Attractiveness Analysis, By Product

Figure 91:  Global Narcolepsy Treatment Market Value Share Analysis, By Product, 2021 & 2028

Figure 92:  Global Narcolepsy Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 93:  Global Narcolepsy Treatment Market Value Share Analysis, By Distribution Channel, 2021 & 2028

Figure 94:  Global Narcolepsy Treatment Market Size and Y-o-Y, 2013 - 2021

Figure 95:  Global Narcolepsy Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Sleep Aid Devices Market

Published : February 2019

Healthcare

Wearable Sleep Trackers Market

Published : December 2021

Healthcare

Positive Air Pressure Devices Market

Published : November 2017

Healthcare

Sleep Apnea Diagnostic Systems Market

Published : August 2021

Google translate

Narcolepsy Treatment Market